Cargando…
Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use
One of the main challenges to paediatric drug administration is swallowing difficulties, hindering the acceptability of the medicine and hence clinical outcomes. This study aims at developing a child-appropriate dosage form, the orodispersible mini-tablet (ODMT), using the model drug carbamazepine (...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860831/ https://www.ncbi.nlm.nih.gov/pubmed/36678881 http://dx.doi.org/10.3390/pharmaceutics15010250 |
_version_ | 1784874688116162560 |
---|---|
author | Hu, Jiayu Fitaihi, Rawan Abukhamees, Shorooq Abdelhakim, Hend E. |
author_facet | Hu, Jiayu Fitaihi, Rawan Abukhamees, Shorooq Abdelhakim, Hend E. |
author_sort | Hu, Jiayu |
collection | PubMed |
description | One of the main challenges to paediatric drug administration is swallowing difficulties, hindering the acceptability of the medicine and hence clinical outcomes. This study aims at developing a child-appropriate dosage form, the orodispersible mini-tablet (ODMT), using the model drug carbamazepine (CBZ). This dosage form was prepared and 3D-printed via a semi-solid extrusion technique. Design of Experiment methods were applied for optimising the formulation. The formulation with 40% (w/w) of SSG (superdisintegrant) and 5% (w/w) of PVP K30 (binder) was selected and loaded with CBZ. The drug-loaded tablets were characterised by a mean hardness of 18.5 N and a disintegrating time of 84 s, along with acceptable friability. The mean drug loading ratio of the tablets was tested as 90.56%, and the drug release rate in 0.1 M HCl reached 68.3% at 45 min. Excipients showed proper compatibility with the drug in physical form analysis. Taste assessment via an E-tongue was also conducted, where the drug did not show bitter taste signals at a low concentration in the taste assessment, and the sweetener also blocked bitterness signals in the testing. To this end, ODMTs were found to be potential candidates for child-appropriate dosage forms delivering CBZ. |
format | Online Article Text |
id | pubmed-9860831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98608312023-01-22 Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use Hu, Jiayu Fitaihi, Rawan Abukhamees, Shorooq Abdelhakim, Hend E. Pharmaceutics Article One of the main challenges to paediatric drug administration is swallowing difficulties, hindering the acceptability of the medicine and hence clinical outcomes. This study aims at developing a child-appropriate dosage form, the orodispersible mini-tablet (ODMT), using the model drug carbamazepine (CBZ). This dosage form was prepared and 3D-printed via a semi-solid extrusion technique. Design of Experiment methods were applied for optimising the formulation. The formulation with 40% (w/w) of SSG (superdisintegrant) and 5% (w/w) of PVP K30 (binder) was selected and loaded with CBZ. The drug-loaded tablets were characterised by a mean hardness of 18.5 N and a disintegrating time of 84 s, along with acceptable friability. The mean drug loading ratio of the tablets was tested as 90.56%, and the drug release rate in 0.1 M HCl reached 68.3% at 45 min. Excipients showed proper compatibility with the drug in physical form analysis. Taste assessment via an E-tongue was also conducted, where the drug did not show bitter taste signals at a low concentration in the taste assessment, and the sweetener also blocked bitterness signals in the testing. To this end, ODMTs were found to be potential candidates for child-appropriate dosage forms delivering CBZ. MDPI 2023-01-11 /pmc/articles/PMC9860831/ /pubmed/36678881 http://dx.doi.org/10.3390/pharmaceutics15010250 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hu, Jiayu Fitaihi, Rawan Abukhamees, Shorooq Abdelhakim, Hend E. Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use |
title | Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use |
title_full | Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use |
title_fullStr | Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use |
title_full_unstemmed | Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use |
title_short | Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use |
title_sort | formulation and characterisation of carbamazepine orodispersible 3d-printed mini-tablets for paediatric use |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860831/ https://www.ncbi.nlm.nih.gov/pubmed/36678881 http://dx.doi.org/10.3390/pharmaceutics15010250 |
work_keys_str_mv | AT hujiayu formulationandcharacterisationofcarbamazepineorodispersible3dprintedminitabletsforpaediatricuse AT fitaihirawan formulationandcharacterisationofcarbamazepineorodispersible3dprintedminitabletsforpaediatricuse AT abukhameesshorooq formulationandcharacterisationofcarbamazepineorodispersible3dprintedminitabletsforpaediatricuse AT abdelhakimhende formulationandcharacterisationofcarbamazepineorodispersible3dprintedminitabletsforpaediatricuse |